Biotech China 2014
3rd Neurological Biomarkers
Hyatt Regency Mission Bay San Diego
1441 Quivira Rd
San Diego, CA USA
http://www.gtcbio.com/conference/neurological-biomarkers-overview
3rd Neurological Biomarkers 
GTC
http://www.gtcbio.com/conference/neurological-biomarkers-overview
Hyatt Regency Mission Bay San Diego
1441 Quivira Rd
San Diego
CA  USA

Schedule of Presentations:

Wednesday, March 19, 2014
12:55:00 Chairperson's Opening Remarks
13:00:00 A post-GWAS Method for Translating Statistical Associations to Disease-relevant Pathways Allen Roses
13:45:00 Lessons Learned from Oncology Biomarker and Companion Diagnostics Development Mara G Aspinall
14:30:00 The Reality of Incorporating Biomarkers and Genetics into Drug Development, are We There yet?
15:15:00 Afternoon Networking Break
15:50:00 Executive Panel: Companion Diagnostics & Partnering Strategies Mara Aspinall, Scott D Patterson
16:50:00 Day 1 Concludes
Thursday, March 20, 2014
06:00:00 Strategies for Using PET Imaging for Personalized Medicine
07:00:00 Continental Breakfast & Registration
08:00:00 Chairperson's Introduction Andreas Jeromin
08:15:00 Advances in Translational Neuroscience
09:05:00 The Michael J Fox Foundation Strategy for Discovery and Validation of Parkinson’s Disease Biomarkers Mark Frasier
09:30:00 Chief Executive Officer, Co-Founder, Molecular NeuroImaging
09:55:00 Morning Networking Break
10:30:00 Coalition Against Major Diseases (CAMD): Regulatory Science Accelerates Drug Development and Biomarkers for Neurodegenerative Diseases Diane Stephenson
10:55:00 Patrizia Fanara, Vice President, Neuroscience, KineMed Patrizia Fanara
11:45:00 Validation, Qualification and Approval of Biomarkers for Trial Stratification and Early Diagnostic Decisions for Alzheimer’s Disease
12:10:00 Lunch on Your Own
13:40:00 Richard Margolin, Senior Director, Biomarkers, Janssen Alzheimer Immunotherapy
14:05:00 FEATURED PRESENTATION
14:30:00 A New Role for Nonprofits in Drug Discovery: The Myelin Repair Foundation’s Collaborative Research Approach to Accelerating the Next Generation of Multiple Sclerosis Therapeutics
14:55:00 How Biomarkers Can Change the Landscape of ALS Drug Discovery
15:20:00 Afternoon Networking Break
15:50:00 Can Biomarkers Predict Psychosis and Individualize Treatment in the Prodromal Period of Illness? Kristin Cadenhead
16:15:00 A Biomarker Panel and Gender Specific Algorithms to Aid in the Diagnosis of Major Depressive Disorder
16:40:00 Blood-based Gene-expression Predictors of PTSD Risk among Deployed Marines: A Pilot Study Ming Tsuang
17:05:00 Protein Biomarkers for Schizophrenia: Diagnosis and Stratification of Patients
17:30:00 Oral Presentations from Exemplary Submitted Abstracts
18:00:00 Networking Reception and Poster Session
Friday, March 21, 2014
07:00:00 Continental Breakfast
08:00:00 Systems Approaches to Disease: Emerging Technologies and Novel Strategies Including Blood Diagnostics Leroy Hood
08:45:00 The Biomarker Meets Predictive Analytics
09:10:00 Estimating Long-term Alzheimer’s Cascade from Short-term Data Michael Donohue
09:35:00 Revolutionizing Target Identification for Brain Diseases through Computational Systems Biology
10:00:00 Leveraging Big Bata and Big Analytics to Power Drug Discovery and Development Iya G. Khalil
10:25:00 Morning Networking Break
11:00:00 Novel Technologies in Biomarker Development Hongjie Dai
11:25:00 Uncovering Complex Patterns of Biology in Health and Disease with SOMAscan, a Breakthrough Proteomics Platform
11:50:00 Panel Discussion: Non-Profits Perspectives on CNS Biomarkers Jennifer Chang, Diane Stephenson, Mark Frasier, Andreas Jeromin
12:50:00 Lunch Provided by GTC
13:50:00 Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development Felix Frueh
14:50:00 Panel Discussion: Investment Perspectives & Funding Opportunities Andrew Jay, John Reppas, Jeff Karan, Keith Batchelder
15:50:00 Conference Concludes
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.